-
2023/11/13
Takara Bio Announces "SonuAAV™", a Novel AAV Vector for Efficient Gene Transfer to the Inner Ear Organ.
-
2023/11/09
Notice Concerning Differences between the Financial Results Forecasts and the Actual Results
（163KB）
-
2023/11/09
Notice Concerning Revisions to the Financial Results Forecasts
（177KB）
-
2023/11/09
Consolidated Financial Results for the Six Months Ended September 30, 2023 (Under Japanese GAAP)
（427KB）
-
2023/10/12
Construction of the Center for Gene and Cell Processing III, which manufactures mRNA vaccine ingredients and enzymes for mRNA production